Bristol-Myers

URI: https://gptkb.org/entity/Bristol-Myers

GPTKB entity

Predicate	Object
gptkbp:instance_of	gptkb:pharmaceuticals
gptkbp:acquisition	gptkb:Celgene_Corporation
gptkbp:ceo	gptkb:Giovanni_Caforio
gptkbp:founded	1887
gptkbp:founder	gptkb:John_Myers gptkb:William_Mc_Laren_Bristol
gptkbp:headcount	30,000 (2020)
gptkbp:headquarters	gptkb:New_York_City
https://www.w3.org/2000/01/rdf-schema#label	Bristol-Myers
gptkbp:industry	biopharmaceuticals
gptkbp:key_people	gptkb:Lamberto_Andreotti gptkb:Robert_J._Bertolini gptkb:Giovanni_Caforio gptkb:Charles_A._Sanders gptkb:Michael_A._T._Mc_Ginnis
gptkbp:partnership	gptkb:Zymeworks gptkb:Immunomedics gptkb:Iovance_Biotherapeutics gptkb:Astra_Zeneca gptkb:Boehringer_Ingelheim gptkb:Pfizer gptkb:Apexigen gptkb:Regeneron_Pharmaceuticals gptkb:Sangamo_Therapeutics gptkb:Merck_&_Co. gptkb:Bristol-Myers_Squibb_Foundation gptkb:Eli_Lilly_and_Company gptkb:Sorrento_Therapeutics gptkb:Abb_Vie gptkb:Cure_Vac gptkb:Alder_Bio_Pharmaceuticals gptkb:Nant_Kwest gptkb:Nant_Works
gptkbp:products	gptkb:Zeposia gptkb:Reblozyl gptkb:Opdivo gptkb:Eliquis gptkb:Yervoy
gptkbp:research_and_development	$11.4 billion (2020)
gptkbp:revenue	$46.4 billion (2020)
gptkbp:stock_symbol	BMY
gptkbp:subsidiary	gptkb:Juno_Therapeutics gptkb:Bristol-Myers_Squibb_Foundation gptkb:Celgene Myocardia
gptkbp:type	gptkb:public_company
gptkbp:bfsParent	gptkb:Tyrrell_026
gptkbp:bfsLayer	6